Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II

Maebayashi T.; Ishibashi N.; Aizawa T.; Sakaguchi M.; Okada M.

首页> 外文期刊>Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique >Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II

【24h】

Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II

机译：丙型肝炎肝细胞癌的立体定向放射疗法及其与AFP和PIVKA-II的碳水化合物抗原19-9的变化关系

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose. - Assessing the therapeutic effects of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC) takes time. Purpose of our study was to explore the relationships of changes in carbohydrate antigen 19-9 (CA 19-9) with those in the existing markers alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II).

机译：目的。-评估立体定向放射治疗（SBRT）对肝细胞癌（HCC）的治疗效果需要时间。我们的研究目的是探讨碳水化合物抗原19-9（CA19-9）的变化与现有标记物甲胎蛋白（AFP）和维生素K缺乏或拮抗剂II（PIVKA-II）诱导的蛋白质变化之间的关系。

著录项

来源
《Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique》 |2021年第3期|共7页
作者
Maebayashi T.; Ishibashi N.; Aizawa T.; Sakaguchi M.; Okada M.;
展开▼
作者单位

Nihon Univ Sch Med Dept Radiol Itabashi Ku 30-1 Oyaguchi Kami Cho Tokyo 1738610 Japan;

Nihon Univ Sch Med Dept Radiol Itabashi Ku 30-1 Oyaguchi Kami Cho Tokyo 1738610 Japan;

Nihon Univ Sch Med Dept Radiol Itabashi Ku 30-1 Oyaguchi Kami Cho Tokyo 1738610 Japan;

Nihon Univ Sch Med Dept Radiol Itabashi Ku 30-1 Oyaguchi Kami Cho Tokyo 1738610 Japan;

Nihon Univ Sch Med Dept Radiol Itabashi Ku 30-1 Oyaguchi Kami Cho Tokyo 1738610 Japan;

展开▼
收录信息
原文格式 PDF
正文语种 fre
中图分类肿瘤学;
关键词
Hepatocellular carcinoma; Stereotactic body radiotherapy; CA19-9; AFP; PIVKA-II; Biomarkers; HCV;

机译：肝细胞癌;立体定向体放射疗法;CA19-9;AFP;Pivka-II;生物标志物;HCV;

相似文献

外文文献
中文文献
专利

1. The relationship between the hepatitis B virus base core and precore/core promoter mutations and the development of cirrhotic hepatocellular carcinoma and noncirrhotic hepatocellular carcinoma [J] . 徐尧江中国医学文摘：内科学分册（英文版） . 2013,第001期
2. Clinical significance of serum carbohydrate antigen 19-9 and its relationship with blood glucose in patients with type 2 diabetes [J] . 武秀玲中国医学文摘：内科学分册（英文版） . 2013,第004期
3. Higher levels of AFP, AFP-L3, and PIVKA-II in hepatocellular carcinoma recurrence in patients with chronic hepatitis C who achieved sustained virologic response with interferon-free compared with interferon-based therapy [J] . Miyase Shiho, Kugiyama Aya, Tsukano Natsumi, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：慢性丙型肝炎患者的肝细胞癌复发中患者患有慢性丙型肝炎患者的肝细胞癌复发水平更高水平的AFP，AFP-L3和PIVKA-II与干扰素的无干扰素的疗法相比
4. The Efficacy of Serum Carcinoembryonic Antigen (CEA), Cancer Antigen 125 (CA125), Carbohydrate Antigen 19-9 (CA19-9), Carbohydrate Antigen 15-3 (CA15-3), α-Fetoprotein (AFP) and Human Chorionic Gonadotropin (hCG) Levels in Determining the Malignancy of Solitary Pulmonary Nodules [J] . TT Bekci, T Senol, E Maden Journal of International Medical Research . 2009,第2期

机译：血清癌胚抗原（CEA），癌症抗原125（CA125），碳水化合物抗原19-9（CA19-9），碳水化合物抗原15-3（CA15-3），α-甲胎蛋白（AFP）和人绒毛膜促性腺激素（ hCG）测定孤立性肺结节恶性程度的水平
5. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma [J] . Park Sang Joon, Jang Jae Young, Jeong Soung Won, Medicine. . 2017,第11期

机译：AFP，AFP-L3和PIVKA-II及其组合在诊断肝细胞癌中的作用
6. CLINICAL VALUES OF COMBINED HEPATOMA-SPECIFIC AFP FRACTION AND AFP-mRNA DETERMINATION IN DIAGNOSIS AND DIFFERENTIATION OF HEPATOCELLULAR CARCINOMA [C] . Wei Wu, Dengfu Yao, Liwei Qiu, 第四届国际后基因组生命科学技术学术论坛 . 2006

机译：肝细胞特异性AFP馏分结合AFP-mRNA测定在肝细胞癌诊断和鉴别诊断中的临床价值
7. Hepatitis B X antigen promotes "stemness" in the pathogenesis of hepatocellular carcinoma. [D] . Friedman, Tiffany Ilene. 2012

机译：乙型肝炎X抗原在肝细胞癌的发病机理中促进“干性”。
8. Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP [O] . Jong Young Choi, Seung Won Jung, Hee Yeon Kim, 2013

机译：血清总AFP对AFP-L3和PIVKA-II在肝细胞癌中的诊断价值
9. Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation [O] . Seok-Hwan Kim, Deok-Bog Moon, Wan-Joon Kim, 2016

机译：维生素K缺失或拮抗剂-II（PIVKA-II）诱导患有肝细胞癌患者的α-胎儿蛋白（AFP）和蛋白质的术前预诊断值，用于肝细胞癌的肝癌肝脏移植患者
10. Hepatitis B Virus Infection and Hepatocellular Carcinoma: Correlation between IgM Antibody to Hepatitis B Core Antigen, Hepatitis B e Antigen, and Hepatitis B DNA. [R] . Sjogren, M. H., Dusheiko, G. M., Kew, M. C., 1988

机译：乙型肝炎病毒感染和肝细胞癌：乙型肝炎核心抗原，乙型肝炎抗原和乙型肝炎DNa的Igm抗体之间的相关性。

Stereotactic radiotherapy for hepatocellular carcinoma induced by hepatitis C and the relationships of changes in carbohydrate antigen 19-9 with AFP and PIVKA-II

摘要

著录项

相似文献

相关主题

期刊订阅